Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2007-04-09
2009-11-24
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S510000, C514S866000, C514S887000, C514S928000
Reexamination Certificate
active
07622506
ABSTRACT:
This invention relates to compositions containing a compound of formula (I) shown below:Each variable is defined in the specification. Also disclosed are methods of using these compositions to treat acne, psoriasis, and infective skin ulcer.
REFERENCES:
patent: 2005/0222258 (2005-10-01), Wang
patent: 02114973.9 (2004-09-01), None
patent: 03128742.5 (2004-11-01), None
patent: 200310109057.7 (2006-08-01), None
“Psoriasis”, The Columbia Encyclopedia, 2004, Columbia University Press, downloaded from “http://.www.credoreference.com/entry/4294839”, p. 1 of 1.
Lee, “Helicobacter Pylori”, MedicineNet.com, 2005, downloaded from “http://www.medicinenet.com/helicobacter—pylori/article.htm” on Dec. 24, 2008, pp. 1-4 of 4.
Cihakova, Johns Hopkins Medical Institutions: Autoimmune Disease Research Center, “Type 1 Diabetes Mellitus”, 2001, downloaded from “http://autoimmune.pathology.jhmi.edu/diseases.cfm? systemid=3&diseaseid=23”, pp. 1-5 of 5.
Caballero et al., Journal of Foot & Ankle Surgery, 1998, vol. 37(3), pp. 248-255.
Assimopoulou et al. “Analysis of alkannin derivatives fromAlkannaspecies by high-performance liquid chromatography/photodiode array/mass spectrometry”,Biomedical Chromatography, Published online in Wiley InterScience (www.interscience.wiley.com) DOI:10.1002/bmc.705.
Chen et al. “Shikonin, a Component of Chinese Herbal Medicine, Inhibits Chemokine Receptor Function and Suppresses Human Immunodeficiency Virus Type 1”,Antimicrobial Agents and Chemotherapy, Sep. 2003. pp. 2810-2816.
Davisson et al. “Phosphorylation of Isoprenoid Alchohols”,Journal of Organic Chemistry, 1986, 51, pp. 4768-4779.
Kundakovic et al. “Cytotoxicity in vitro of Naphthazarin Derivatives fromOnosma arenaria”, Phytotherapy Research, 20, pp. 602-604 (2006).
Papageorgiou et al. “Recent Advances in Chemistry, Biology and Biotechnology of Alkannins and Shikonins”,Current Organic Chemistry, 2006, 10, pp. 2123-2142.
Plyta et al. “Inhibition of Topoisomerase I by Naphthoquinone Derivatives”,Bioorganic&Medicinal Chemistry Letters, 8 (1998) p. 3385-3390.
Shen et al. “Antimicrobial Activities of Naphthazarins fromArnebia euchroma”, J. Nat. Prod., 2002, 65, pp. 1857-1862.
Shukla et al. “Naphthaquinones ofArnebia nobilis” Phytochemistry, 1971, vol. 10, pp. 1909-1915.
Assimopoulou et al. “Analysis of alkannin derivatives fromAlkannaspecies by high-performance liquid chromatography/photodiode array/mass spectrometry”,Biomedical Chromatography, Published online in Wiley InterScience (www.interscience.wiley.com) DOI:10.1002/bmc.705, 2006.
Chien Du-Shieng
Chu Yi-Wen
Chuang Wu-Chang
Lee Ming-Chung
Marschel Ardin
Occhiuti Rohlicek & Tsao LLP
Polansky Gregg
SunTen Phytotech Co., Ltd.
LandOfFree
Naphthalenedione compounds for treating inflammation related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalenedione compounds for treating inflammation related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalenedione compounds for treating inflammation related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4133708